Many people prescribed GLP-1 drugs for type 2 diabetes (such as Victoza, Ozempic, or tirzepatide) stop taking them, but a surprising number later return to tre…

The Supreme Court has shot down a request from the nation's oldest sitting federal judge, Pauline Newman, to take up her suspension case after she was shelved …

Australia was the first country to issue a ban in late 2025, aiming to reduce the pressures and risks that young users may face on social media, including cybe…

More than 3,000 Australians die by suicide each year, yet one of the strongest known drivers of suicide risk—unemployment—remains largely overlooked in Austral…

Both kratom and one of its active components, 7-OH, have opioid-like effects and are widely available across the US. As health secretary RFK Jr. aims to get 7-…

This handheld device combines red light therapy, microcurrents, sonic vibration, warmth, and a serum to support healthy hair growth.

Mark Lanier, trial lawyer who beat Meta in a landmark social media addiction case, said AI has transformed his work during and before trial.

Season 3 of Cross is in production and creator and showrunner Ben Watkins revealed that the next chapter of the Prime Video drama will explore addiction throug…

Written by Catie Hogan for The Motley Fool -> Oracle's plans to raise $40 billion through debt and equity sparked investor anxiety. The company's remaining p…

(RTTNews) - Genmab A/S (GMAB) reported positive findings from two clinical studies evaluating epcoritamab in elderly patients with newly diagnosed diffuse larg…

Getting testosterone therapy without the right medical care is a growing problem. Here's how to know if you need TRT, and what the risks are.